A200130 Stock Overview
Kolmar BNH Co., Ltd. engages in the research and development of materials used in the functional health food and cosmetics market in South Korea and internationally. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 3/6 |
Dividends | 2/6 |
KOLMAR BNH Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩13,080.00 |
52 Week High | ₩19,970.00 |
52 Week Low | ₩11,630.00 |
Beta | 0.82 |
11 Month Change | -7.43% |
3 Month Change | -13.89% |
1 Year Change | -18.50% |
33 Year Change | -55.28% |
5 Year Change | -50.08% |
Change since IPO | -61.53% |
Recent News & Updates
There's Reason For Concern Over KOLMAR BNH Co.,Ltd.'s (KOSDAQ:200130) Price
Nov 12KOLMAR BNHLtd (KOSDAQ:200130) Will Be Hoping To Turn Its Returns On Capital Around
Jun 21Recent updates
There's Reason For Concern Over KOLMAR BNH Co.,Ltd.'s (KOSDAQ:200130) Price
Nov 12KOLMAR BNHLtd (KOSDAQ:200130) Will Be Hoping To Turn Its Returns On Capital Around
Jun 21The Attractive Combination That Could Earn KOLMAR BNH Co., Ltd. (KOSDAQ:200130) A Place In Your Dividend Portfolio
Mar 23Is KOLMAR BNH Co., Ltd. (KOSDAQ:200130) Trading At A 43% Discount?
Mar 12Can KOLMAR BNH (KOSDAQ:200130) Prolong Its Impressive Returns?
Mar 01What You Need To Know About KOLMAR BNH Co., Ltd.'s (KOSDAQ:200130) Investor Composition
Feb 16Here's Why We Think KOLMAR BNH (KOSDAQ:200130) Is Well Worth Watching
Feb 01Should You Think About Buying KOLMAR BNH Co., Ltd. (KOSDAQ:200130) Now?
Jan 17KOLMAR BNH (KOSDAQ:200130) Has A Rock Solid Balance Sheet
Jan 05KOLMAR BNH Co., Ltd. (KOSDAQ:200130) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
Dec 25KOLMAR BNH (KOSDAQ:200130) Shareholders Booked A 90% Gain In The Last Year
Dec 22KolmarBNH Co., Ltd. (KOSDAQ:200130) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Dec 07Is KolmarBNH (KOSDAQ:200130) Going To Multiply In Value?
Nov 24Shareholder Returns
A200130 | KR Personal Products | KR Market | |
---|---|---|---|
7D | 3.8% | -0.4% | 2.5% |
1Y | -18.5% | -11.3% | -1.1% |
Return vs Industry: A200130 underperformed the KR Personal Products industry which returned -11.3% over the past year.
Return vs Market: A200130 underperformed the KR Market which returned -1.1% over the past year.
Price Volatility
A200130 volatility | |
---|---|
A200130 Average Weekly Movement | 5.3% |
Personal Products Industry Average Movement | 6.5% |
Market Average Movement | 5.7% |
10% most volatile stocks in KR Market | 11.6% |
10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A200130 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A200130's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2004 | 512 | Hwa-Yeong Jung | www.kolmarbnh.co.kr |
Kolmar BNH Co., Ltd. engages in the research and development of materials used in the functional health food and cosmetics market in South Korea and internationally. The company offers cosmetics; and provides total functional health food original development manufacturing services, such as manufacturing tablets, hard capsules, soft capsules, liquids, gels, powder dosage, and various new formulation forms. It offers packaging products, such as PTP/multi-PTP, powder stick/pouch, three-side cloth, four-side, and liquid stick packaging; and ODM consulting services.
KOLMAR BNH Co.,Ltd. Fundamentals Summary
A200130 fundamental statistics | |
---|---|
Market cap | ₩380.85b |
Earnings (TTM) | ₩17.77b |
Revenue (TTM) | ₩611.19b |
21.4x
P/E Ratio0.6x
P/S RatioIs A200130 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A200130 income statement (TTM) | |
---|---|
Revenue | ₩611.19b |
Cost of Revenue | ₩526.25b |
Gross Profit | ₩84.95b |
Other Expenses | ₩67.18b |
Earnings | ₩17.77b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 610.34 |
Gross Margin | 13.90% |
Net Profit Margin | 2.91% |
Debt/Equity Ratio | 54.1% |
How did A200130 perform over the long term?
See historical performance and comparison